Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Condition After Xeljanz Treatment in Rheumatoid Arthritis Patients

NCT02157012 is registered in ClinicalTrials.gov with Shinshu University as lead sponsor.

NCT NCT02157012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02157012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Condition After Xeljanz Treatment in Rheumatoid Arthritis Patients
Lead sponsor
Shinshu University
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2014
Completion date
March 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis